Lecanemab: new Alzheimer's drug against amyloid

Send us Fan MailDr. Mia talks about the newly released preliminary results of anti-amyloid drug: lecanemab, the context of this newest drug development, and more questions than answers going forward. News release of clinical trial Clarity AD (lecanemab) trial resultsBiogen & Eisai's 50/50 relationship for lecanemabOther trials including lecanemabBiogen's recent $900 million lawsuit settlement due to improper physician paymentARIA (Amyloid-related Imaging Abnormality): key side effects in lecanemabTranscript & more at www.miayangmd.com*Disclaimer: views expressed are Dr. Mia Yang's solely and do not represent her employer, National Institute of Health (NIH), or Patient-Centered Outcomes Research Institute (PCORI). Dr. Mia has no pharmaceutical company funding. Support the showVideo on Ask Dr. Mia YouTube channelTranscripts on www.miayangmd.com. Transcripts are automatically generated and may contain minor inaccuracies. Email: [email protected] expressed are exclusive of Dr. Mia Yang and not reflective of her or guest speaker's employers or funders.